{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:46:14Z","timestamp":1791301574013,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.10.085","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T08:45:09Z","timestamp":1383727509000},"page":"26-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Reduction in HPV 16\/18 prevalence in sexually active young women following the introduction of HPV immunisation in England"],"prefix":"10.1016","volume":"32","author":[{"given":"D.","family":"Mesher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Soldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Howell-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Panwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Manyenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Beddows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.N.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.10.085_bib0005","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1016\/j.vaccine.2010.07.007","article-title":"Sustained efficacy and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women","volume":"28","author":"De Carvalho","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0010","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","author":"Lehtinen","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0015","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0020","unstructured":"World Health Organization, Number of countries having introduced HPV vaccines to date, Available from http:\/\/www.who.int\/nuvi\/hpv\/decision_implementation\/en\/index.html (accessed September 2012)."},{"key":"10.1016\/j.vaccine.2013.10.085_bib0025","unstructured":"Department of Health, Annual HPV vaccine uptake in England: 2010\/11, Available from URL: https:\/\/www.wp.dh.gov.uk\/immunisation\/files\/2012\/03\/120319_HPV_UptakeReport2010-11-revised_acc.pdf (accessed October 2012)."},{"key":"10.1016\/j.vaccine.2013.10.085_bib0030","unstructured":"National Chlamydia Screening Programme, National Chlamydia Screening Programme Standards, sixth ed., Available from URL: http:\/\/www.chlamydiascreening.nhs.uk\/ps\/resources\/core-requirements\/NCSP%20Standards%20Edition%206_Accompanying%20Information%20Document_October%202012.pdf (accessed June 2013)."},{"key":"10.1016\/j.vaccine.2013.10.085_bib0035","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.vaccine.2012.04.006","article-title":"Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation","volume":"30","author":"Howell-Jones","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0040","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/jmv.22167","article-title":"Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males","volume":"83","author":"Bissett","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0050","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of hybrid capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0055","first-page":"367","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/OLQ.0b013e318064c8c5","article-title":"A comparison of cervical and vaginal human papillomavirus","volume":"34","author":"Castle","year":"2007","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0070","doi-asserted-by":"crossref","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom","volume":"337","author":"Jit","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0075","doi-asserted-by":"crossref","first-page":"d5775","DOI":"10.1136\/bmj.d5775","article-title":"Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model","volume":"343","author":"Jit","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0085","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1073\/pnas.94.12.6571","article-title":"Vaccination against colonizing bacteria with multiple serotypes","volume":"94","author":"Lipsitch","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/jis494","article-title":"Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types","volume":"206","author":"Durham","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PDM.0b013e31827f3f7e","article-title":"Effect of HPV assay choice on perceived prevalence in a population-based sample","volume":"22","author":"Cuschieri","year":"2013","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0100","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02831-12","article-title":"An HPV testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR and a novel E6 high-risk multiplex type-specific genotyping PCR","author":"van Alewijk","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1349-7006.2011.01922.x","article-title":"Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers","volume":"102","author":"Mori","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0110","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JCM.00539-06","article-title":"Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR","volume":"44","author":"Van Doorn","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/JCM.00991-09","article-title":"Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay","volume":"48","author":"Schmitt","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0120","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"Global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/sti.2010.047027","article-title":"Who is being tested by the English National Chlamydia Screening Programme? A comparison with national probability survey data","volume":"87","author":"Riha","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0130","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.085_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, national health and nutrition examination surveys, 2003\u20132010","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:24:07Z","timestamp":1539221047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13014928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13014928"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in HPV 16\/18 prevalence in sexually active young women following the introduction of HPV immunisation in England","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}